Stephen Poor

Company: Novartis AG

Job title: Clinical Development Ophthalmology & Global Drug Development, Medical Lead Ophthalmology

Seminars:

Panel Discussion: Working Around Clinical Trial Challenges for Retinal Vascular Disease Drug Development 5:15 pm

• Discussing challenges of getting the next generation of therapeutics approved for DME and nAMD • Highlighting the novel end points beyond BCVA to establish meaningful differentiation from VEGF therapy • Overcoming challenges with regulators and payers to get approval and funding for therapiesRead more

day: Day One